Enliven Therapeutics
ELVN
#5492
Rank
A$1.69 B
Marketcap
$34.66
Share price
-2.36%
Change (1 day)
102.05%
Change (1 year)

Enliven Therapeutics (ELVN) - Net assets

Net assets on the balance sheet as of September 2024 : A$0.46 Billion

According to Enliven Therapeutics's latest financial reports the company has A$0.46 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enliven Therapeutics - Net assets on balance sheet (from 2021 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$0.36 B-419.71%
2022-12-31$-A$0.12 Billion90.84%
2021-12-31$-A$59.16 Million124.03%
2020-12-31$-A$26.41 Million